Alongside our scientists, world-renowned academics and researchers study our strains to learn more about the power of probiotics for microbiome health. Learn more about their findings here.
In our latest whitepaper, a recent study shows that BLIS K12™ stimulates the production of antibodies specific to SARS CoV-2 virus in people that have been vaccinated for COVID-19 and led to accelerated viral clearance.
In our latest whitepaper, shows BLIS M18™ significantly reduces gingivitis in young adults and improved dental health in pre-schoolers that had dental caries, reducing them by 81%.
Halitosis (bad breath) can be a major source of embarrassment and social anxiety for some people. Bad breath is estimated to affect half the adult population at some time, to some extent. BLIS K12™ has been scientifically proven to inhibit bacteria that cause halitosis…
Two new studies have revealed that BLIS K12™ stimulates the production of interferon gamma and immunoglobulin A (sIgA) levels in the mouth…
Three independent studies reveal continued support that consumption of Streptococcus salivarius (BLIS K12™) is beneficial in reducing the frequency and length of respiratory illness caused by both viruses and bacteria.